Skip to main
RVTY

Revvity Inc (RVTY) Stock Forecast & Price Target

Revvity Inc (RVTY) Analyst Ratings

Based on 13 analyst ratings
Hold
Strong Buy 8%
Buy 23%
Hold 69%
Sell 0%
Strong Sell 0%

Bulls say

Revvity is well-positioned to capitalize on the growing demand for advanced research tools and diagnostics, and its strategic acquisitions have diversified its portfolio. The signals software segment also provides a unique opportunity for growth, with its AI-enabled drug discovery platform and potential collaborations with biotech and pharma companies. Revvity's financial strength, coupled with its strong product portfolio and potential for growth, make it a promising investment opportunity for shareholders.

Bears say

Revvity is facing headwinds from a decline in birth rates and expected tough comps for its reproductive health business. The recent weakening in pharmaceutical and biotech spending is also impacting its bottom line and its software segment is facing newfound competition. Despite management's optimistic outlook, organic growth and margin targets are falling short, and the upcoming divestiture of the China immunodiagnostics business raises concerns about future growth potential.

Revvity Inc (RVTY) has been analyzed by 13 analysts, with a consensus rating of Hold. 8% of analysts recommend a Strong Buy, 23% recommend Buy, 69% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Revvity Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Revvity Inc (RVTY) Forecast

Analysts have given Revvity Inc (RVTY) a Hold based on their latest research and market trends.

According to 13 analysts, Revvity Inc (RVTY) has a Hold consensus rating as of Sep 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $117.77, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $117.77, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Revvity Inc (RVTY)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.